Table 4 Pathway enrichment results for the target genes selected for UC.

From: Aggregative trans-eQTL analysis detects trait-specific target gene sets in whole blood

Component

Category

Pathway

Adjusted p value

Genes in pathway

Genes overlap

Novel genes overlap

1

GO

Regulation of Immune system (GO: 0002683)

8.5  ×  10−09

1606

25

11

Lymphocyte activation (GO: 0046649)

8.5 × 10−09

709

18

8

Regulation of T-cell activation (GO: 0050863)

2.9 × 10−06

311

11

6

Hallmark

IL2 STAT5 signaling

3.2 × 10−10

200

10

5

G2M checkpoint

2.6 × 10−03

200

4

4

Curated

PILON_KLF1_TARGETS_DN

2.5 × 1005

854

11

4

KEGG: Endocytosis

3.2 × 10−02

181

5

3

Reactome: Adaptive immune system

2.1 × 10−02

807

10

3

Immunologic Signatures

GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP

6.9 × 10−08

200

10

8

GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN

4.5 × 10−16

191

16

7

GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP

3.2 × 10−07

196

11

6

2

GO

Defense Response (GO: 0006952)

2.0 × 10−04

1684

11

4

Inflammatory Response (GO: 0022610)

1.2 × 10−03

714

7

2

Curated

JAATINEN_HEMATOPOIETIC_STEM_CELL_DN

4.7 × 10−04

233

6

3

Immunologic Signatures

GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP

2.1 × 10−12

195

11

4

GSE10325_CD4_TCELL_VS_BCELL_DN

5.8 × 10−08

193

8

3

  1. Several selected top pathways containing novel genes across different categories are shown here. See Supplementary Data 57 for results on all the significant pathways for the selected in ARCHIE components 1 and 2, respectively.